News

Filter

Current filters:

Eisaiamatuximab

US unit of Eisai in research pact with Japanese university for amatuximab for pancreatic cancer

19-11-2010

Japanese drug major Eisai’s (TYO: 4532) US subsidiary Morphotek has entered into a sponsored research…

amatuximabEisaiOncologyPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top